Patient self-management of anticoagulation: An idea whose time has come

Annals of Internal Medicine

Volumn 142, Issue 1, 2005, Pages 73-74

  Beyth, Rebecca J ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTIVITAMIN K;

ANTICOAGULANT THERAPY; BLEEDING; HUMAN; PATIENT CARE; PRIORITY JOURNAL; REVIEW; SELF MEDICATION; THROMBOEMBOLISM; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 11244286139     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-142-1-200501040-00014     Document Type: Review

References (16)

1. Ansell J, Hirsh J, Dalen J, Bussey H, Anderson D, Poller L, et al. Managing oral anticoagulant therapy. Chest. 2001;119:22S-38S. [PMID: 11157641]
2. Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness: the chronic care model, Part 2. JAMA. 2002;288: 1909-14. [PMID: 12377092]
3. Holman H, Lorig K. Patients as partners in managing chronic disease. Partnership is a prerequisite for effective and efficient health care [Editorial]. BMJ. 2000;320:526-7. [PMID: 10688539]
4. Von Korff M, Gruman J, Schaefer J, Curry SJ, Wagner EH. Collaborative management of chronic illness. Ann Intern Med. 1997;127:1097-102. [PMID: 9412313]
5. Funnell MM, Anderson RM, Arnold MS, Barr PA, Donnelly M, Johnson PD, et al. Empowerment: an idea whose time has come in diabetes education. Diabetes Educ. 1991;17:37-41. [PMID: 1986902]
6. Schmitt L, Speckman J, Ansell J. Quality assessment of anticoagulation dose management: comparative evaluation of measures of time-in-therapeutic range. J Thromb Thrombolysis. 2003;15:213-6. [PMID: 14739631]
7. Menéndez-Jándula B, Souto JC, Oliver A, Montserrat I, Quintana M, Gich I, et al. Comparing self-management of oral anticoagulant therapy with clinic management. A randomized trial. Ann Intern Med. 2005;142:1-10.
8. Samsa GP, Matchar DB. Relationship between test frequency and outcomes of anticoagulation: a literature review and commentary with implications for the design of randomized trials of patient self-management. J Thromb Thrombolysis. 2000;9:283-92. [PMID: 10728029]
9. Meier DJ, Sonnad SS, Merz JC, Fay WP. Comparison of narrow versus standard target INR ranges [Abstract]. J Am Coll Cardiol. 2002;39:272a.
10. Palareti G, Legnani C, Manotti C. The first months of oral anticoagulant treatment are associated with a very low quality of laboratory control [Abstract]. Data from the Iscoat Study. Thromb Haemost. 1999;82:549.
11. Azar AJ, Deckers JW, Rosendaal FR, van Bergen PF, van der Meer FJ, Jonker JJ, et al. Assessment of therapeutic quality control in a long-term anticoagulant trial in post-myocardial infarction patients. Thromb Haemost. 1994;72: 347-51. [PMID: 7855782]
12. Gadisseur AP, Breukink-Engbers WG, van der Meer FJ, van den Besselaar AM, Sturk A, Rosendaal FR. Comparison of the quality of oral anticoagulant therapy through patient self-management and management by specialized anticoagulation clinics in the Netherlands: a randomized clinical trial. Arch Intern Med. 2003;163:2639-46. [PMID: 14638565]
13. Gadisseur AP, Van Der Meer FJ, Rosendaal FR. Sustained intake of paracetamol (acetaminophen) during oral anticoagulant therapy with coumarins does not cause clinically important INR changes: a randomized double-blind clinical trial. J Thromb Haemost. 2003;1:714-7. [PMID: 12871405]
14. Pattacini C, Manotti C, Pini M, Quintavalla R, Dettori AG. A comparative study on the quality of oral anticoagulant therapy (warfarin versus acenocoumarol). Thromb Haemost. 1994;71:188-91. [PMID: 8191397]
15. Rosendaal FR, Cannegieter SC, van der Meer FJ, Briet E. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost. 1993;69:236-9. [PMID: 8470047]
16. Schulman S. Clinical practice. Care of patients receiving long-term anticoagulant therapy. N Engl J Med. 2003;349:675-83. [PMID: 12917305]